Dietary supplements for preventing postnatal depression

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 10, 2013, Pages

  Miller, Brendan J ^a   Murray, Linda ^b   Beckmann, Michael M ^c   Kent, Terrence ^d   Macfarlane, Bonnie ^c  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c Mater Health Services   (Australia)

^d Raceview Surgery   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; PLACEBO; SELENIUM;

BECK DEPRESSION INVENTORY; DIETARY SUPPLEMENT; DRUG WITHDRAWAL; EDINBURGH POSTNATAL DEPRESSION SCALE; HUMAN; MAJOR DEPRESSION; NEWBORN INTENSIVE CARE; POSTNATAL DEPRESSION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; DIET SUPPLEMENTATION; FEMALE; PATIENT DROPOUTS; PREGNANCY; PRENATAL CARE; PUERPERAL DEPRESSION; STATISTICS; DEPRESSION, POSTPARTUM; STATISTICS AND NUMERICAL DATA;

DEPRESSION, POSTPARTUM; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; PATIENT DROPOUTS; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENIUM;

EID: 84899469417     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009104.pub2     Document Type: Review

References (103)

1. Mokhber N, Namjoo M, Tara F, Boskabadi H, Rayman MP, Ghayour-Mobarhan M, et al.Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial. Journal of Maternal-Fetal and Neonatal Medicine 2011;24(1):104-8.
2. Mozurkewich E, Chilimigras J, Klemens C, Keeton K, Allbaugh L, Hamilton S, et al.The mothers, Omega-3 and mental health study protocol. BMC Pregnancy and Childbirth 2011;11:46.
3. Mozurkewich E, Clinton C, Chilimigras J, Hamilton S, Allbaugh L, Berman D, et al.The Mothers, Omega-3 & Mental Health Study: a double-blind, randomized controlled trial. American Journal of Obstetrics and Gynecology 2013;208(1 Suppl):S19-S20.
4. Mozurkewich EL, Clinton CM, Chilimigras JL, Hamilton SE, Allbaugh LJ, Berman DR, et al.The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. American Journal of Obstetrics and Gynecology 2013;208(4):313.e1-313.e9.
5. Romero V, Stolberg V, Chensue S, Clinton C, Djuric Z, Berman D, et al.Developmental programming for allergic disease: a secondary analysis of the Mothers, Omega-3 and Mental Health Study. American Journal of Obstetrics and Gynecology 2013;208(1 Suppl):S24.
6. Romero VC, Somers EC, Stolberg V, Clinton C, Chensue S, Djuric Z, et al.Developmental programming for allergy: a secondary analysis of the Mothers, Omega-3, and Mental Health Study. American Journal of Obstetrics and Gynecology 2013;208(4):316.e1-e.6.
7. Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, et al.Maternal iron deficiency anemia affects postpartum emotions and cognition. Journal of Nutrition 2005;135(2):267-72.
8. Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009;33(1):49-52.
9. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, et al.Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Immunology 2003;112(6):1178-84.
10. Mattes E, McCarthy S, Gong G, van Eekelen JA, Dunstan J, Foster J, et al.Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain, Behavior, & Immunity 2009;23(3):380-8.
11. Freeman MP, Hibbeln J, Wisner K, Watchman M, Brumbach B, Hill R, et al.Double-blind dose-finding study of omega-3 fatty acids for postpartum depression. Neuropsychopharmacology 2004;29(Suppl 1):S102.
12. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatrica Scandinavica 2006;113(1):31-5.
13. Freeman MP, Sinha P. Tolerability of omega-3 fatty acid supplements in perinatal women. Prostaglandins Leukotrienes & Essential Fatty Acids 2007;77(3-4):203-8.
14. Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. Journal of Affective Disorders 2008;110(1-2):142-8.
15. Freeman MP, Davis MF. Supportive psychotherapy for perinatal depression: preliminary data for adherence and response. Depression and Anxiety 2010;27(1):39-45.
16. Harrison-Hohner J, Coste S, Dorato V, Curet LB, McCarron D, Hatton D. Prenatal calcium supplementation and postpartum depression: an ancillary study to a randomized trial of calcium for prevention of preeclampsia. Archives of Womens Mental Health 2001;3:141-6.
17. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. American Journal of Obstetrics and Gynecology 2003;188(5):1348-53.
18. Makrides M. A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) (accessed 6 December 2005).
19. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, et al.Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010;304(15):1675-83.
20. Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Australian and New Zealand Journal of Psychiatry 2008;42(3):199-205.
21. Smith Fawzi MC, Kaaya SF, Mbwambo J, Msamanga GI, Antelman G, Wei R, et al.Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting. HIV Medicine 2007;8(4):203-12.
22. Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, et al.Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry 2008;69(4):644-51.
23. Judge MP, Beck CT, Durham H, Mckelvey MM, Lammi-Keefe CJ. Maternal docosahexaenoic acid (DHA, 22:6n-3) consumption during pregnancy decreases postpartum depression (PPD) symptomatology. FASEB Journal 2011;25:349.7.
24. Adewuya AO, Ola BO, Aloba OO, Mapayi BM, Okeniyi JA. Impact of postnatal depression on infants' growth in Nigeria. Journal of Affective Disorders 2008;108(1-2):191-3.
25. Affonso DD, Anindya KD, Horowitz JA, Mayberry, LJ. An international study exploring levels of postpartum depressive symptomatology. Journal of Psychosomatic Research 2000;49(3):207-16.
26. Albacar G, Sans T, Martin-Santos R, Garcia-Esteve L, Guillamat R, Sanjuan J, et al.An association between plasma ferritin concentrations measured 48h after delivery and postpartum depression. Journal of Affective Disorders 2011;131(1):136-42.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-IV-TR). 4th Edition. Washington, DC: American Psychiatric Association, 2000.
28. Austin MP, Priest SR, Sullivan EA. Antenatal psychosocial assessment for reducing perinatal mental health morbidity. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD005124.pub2]
29. Azaïs-Braesco V, Pascal G. Vitamin A in pregnancy: requirements and safety limits. American Journal of Clinical Nutrition 2000;71(5):1325S-1333S.
30. Beck AT, Ward C, Mendelson M. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561-71.
31. Beck CT. Maternal depression and child behaviour problems: a meta-analysis. Journal of Advanced Nursing 1999;29(3):623-9.
32. Beck CT, Driscoll JW. Postpartum Mood and Anxiety Disorders: a Clinician's Guide. Sudbury, MA: Jones and Bartlett Publishers, 2006.
33. Boyce P. Personality dysfunction, marital problems, and postnatal depression. In: Cox J, Holden J editor(s). Perinatal Psychiatry: Use and Misuse of the Edinburgh Postnatal Depression Scale. London: Gaskell, 1994.
34. Breznitz Z, Friedman SL. Toddlers' concentration: does maternal depression make a difference?. Journal of Child Psychiatry & Psychiatry & Allied Disciplines 1988;29(3):267-79.
35. Brockington IF. Motherhood and Mental Health. Oxford, UK: Oxford University Press, 1996.
36. Brockington I. Diagnosis and management of post-partum disorders: a review. World Psychiatry 2004;3(2):89-95.
37. Buist A. Child abuse, postpartum depression and parenting difficulties: a literature review of associations. Australian and New Zealand Journal of Psychiatry 1998;32:370-8.
38. Cooper P, Murray L. The course and recurrence of postnatal depression. British Journal of Psychiatry 1995;166:191-5.
39. Cooper P, Murray L. Postnatal depression. BMJ 1998;316:1884-6.
40. Corwin E, Murray-Kolb L, Beard J. Low hemoglobin level is a risk factor for postpartum depression. Journal of Nutrition 2003;133:4139-42.
41. Cox A, Puckering C, Pound A, Mills M. The impact of maternal depression in young children. Journal of Child Psychology & Psychiatry & Allied Disciplines 1987;28(6):917-28.
42. Cox J, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 1987;150:782-6.
43. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. British Journal of Psychiatry 1993;163:27-31.
44. Cox JL, Holden J. Perinatal Mental Health: a Guide to the Edinburgh Postnatal Depression Scale. London: RCPsych Publications, 2003.
45. Cummings E, Davies P. Maternal depression and child development. Journal of Child Psychology & Psychiatry & Allied Disciplines 1994;35(1):73-112.
46. Dalton K. Depression after childbirth. BMJ 1982;284:1331-2.
47. Deave T, Heron J, Evans J, Emond A. The impact of maternal depression in pregnancy on early child development. BJOG: an international journal of obstetrics and gynaecology 2008;115(8):1043-51.
48. Dennis CL, Creedy DK. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD001134.pub2]
49. Dennis CL, Leinic CL. Postpartum depression help-seeking barriers and maternal treatment preferences: a qualitative systematic review. Birth 2006;33(4):323-31.
50. Dennis CL, Hodnett ED. Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006116.pub2]
51. Dennis CL, Ross LE, Grigoriadis S. Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006309.pub2]
52. Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD001690.pub2]
53. Dennis CL, Allen K. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD006795.pub2]
54. Dennis CL, Hodnett E, Kenton L, Weston J, Zupancic J, Stewart DE, et al.Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ 2009;338:a3064.
55. Fisher J, Cabral de Mello M, Izutsu T. Contemporary Topics in Women's Mental Health. Singapore: Wiley-Blackwell, 2009.
56. Fisher J, Cabral de Mello M, Patel V, Rahman A, Tran T, Holton S, et al.Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review. Bulletin of the World Health Organization 2012;90(2):139G-149G.
57. Forman DR, O'Hara MW, Stuart S, Gorman LL, Larsen KE, Coy KC. Effective treatment for postpartum depression is not sufficient to improve the developing mother-child relationship. Development and Psychopathology 2007;19(2):585-602.
58. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Paediatrics 2009;124(4):e547-e556.
59. Freeman MP. Complementary and alternative medicine for perinatal depression. Journal of Affective Disorders 2009;112(1-3):1-10.
60. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism 2002;13(3):100-5.
61. Gibbon K. Developments in perinatal mental health assessments. British Journal of Midwifery 2004;12(12):754-60.
62. Gibson J, McKenzie-McHarg K, Shakespeare J, Price J, Gray R. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatrica Scandinavica 2009;119(5):350-64.
63. Gjerdingen D, Crow S, McGovern P, Miner M, Center B. Changes in depressive symptoms over 0-9 months postpartum. Journal of Women's Health 2011;20(3):381-6.
64. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
65. Hanley J. Perinatal Mental Health. Singapore: Wiley-Blackwell, 2009.
66. Harpham T, Huttly S, De Silva MJ, Abramsky T. Maternal mental health and child nutritional status in four developing countries. Journal of Epidemiology & Community Health 2005;59(12):1060-4.
67. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. Journal of Affective Disorders 2002;69:15-29.
68. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
69. Hipwell AE, Goossens FA, Melhuish EC, Kumar R. Severe maternal psychopathology and infant-mother attachment. Developmental Psychopathology 2000;12(2):157-75.
70. Hoffbrand SE, Howard L, Crawley H. Antidepressant treatment for post-natal depression. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002018]
71. Holden JM. Postnatal depression: its nature, effects and identification using the Edinburgh postnatal depression scale. Birth 1991;18(4):211-21.
72. Hoogendijk W, Lips P, Dik MG, Deeg D, Beekman A, Penninx B. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Archives of General Psychiatry 2008;65(5):508-12.
73. Howard L, Hoffbrand SE, Henshaw C, Boath L, Bradley E. Antidepressant prevention of postnatal depression. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD004363.pub2]
74. Huang HL, Chuang LT, Li HH, Lin CP, Glew R. Docosahexaenoic acid in maternal and neonatal plasma phospholipids and milk lipids of Taiwanese women in Kinmen: fatty acid composition of maternal blood, neonatal blood and breast milk. Lipids in Health and Disease 2013;12(27):1-8. [DOI: 10.1186/1476-511X-12-27]
75. Kendall-Tackett K, Duffy L, Zollo L, Geck L, Holmes A, Dodge J, et al.A Breastfeeding-Friendly Approach to Depression in New Mothers A Curriculum and Resource Guide for Health Care Providers. The New Hampshire Breastfeeding Task Force Website: http://www.lllflorida.com/Web%20Leader/pp%20depression%20curriculum.pdf 2007. Accessed 26th March 2013.
76. Kendell RE, Chalmers L, Platz C. The epidemiology of puerperal psychoses. British Journal of Psychiatry 1987;150:662-73.
77. Lobato G, Moraes C, Dias A, Reichenheim M. Postpartum depression according to time frames and sub-groups: a survey in primary health care settings in Rio de Janeiro, Brazil. Archives of Women's Mental Health 2011;14(3):187-93.
78. Marangell LB, Martinez JM, Zboyan HA, Chong H, Puryear LJ. Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depression Anxiety 2004;19:20-3.
79. Mayberry L, Affonso D. Infant temperament and postpartum depression: a review. Health Care for Women International 1993;14(2):204-11.
80. Miller LJ. Postpartum depression. JAMA 2002;287:762-5.
81. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. American Journal of Clinical Nutrition 2002;76(5):1158S-1161S.
82. Miyake Y, Sasaki S, Tanaka K, Yokoyama T, Ohya Y, Fukushima W, et al.Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: the Osaka Maternal and Child Health Study. Journal of Affective Disorders 2006;96(1-2):133-8.
83. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
84. Murray L. The impact of postnatal depression on infant development. Journal of Child Psychology and Psychiatry 1992;33(3):543-61.
85. Murray L, Fiori-Cowley A, Hooper R, Cooper P. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Development 1996;67(5):2512-26.
86. Murray L, Sinclair D, Cooper P, Ducournau P, Turner P, Stein A. The socioemotional development of 5-year-old children of postnatally depressed mothers. Journal of Child Psychology & Psychiatry & Allied Disciplines 1999;40(8):1259-71.
87. NHMRC. Postnatal depression: a systematic review of published scientific literature to 1999. Commonwealth of Australia 1999.
88. Nott P. Extent, timing and persistence of emotional disorders following childbirth. British Journal of Psychiatry 1987;151:523-7.
89. O'Hara M, Swain A. Rates and risk of postpartum depression - a meta-analysis. International Review of Psychiatry 1996;8(1):37-54.
90. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. Journal of Clilnical Psychiatry 2004;65(2):230-7.
91. Pedros-Rosello A. Postpartum depression and childrearing style on child development. In: Rosenfeld A editor(s). New Research on Postpartum Depression. New York: Nova, 2007:105-30.
92. Pitt B. Maternity blues. British Journal of Psychiatry 1973;122:431-3.
93. Rees AM, Austin MP, Parker G. Role of omega-3 fatty acids as a treatment for depression in the perinatal period. Australian and New Zealand Journal of Psychiatry 2005;39(4):274-80.
94. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
95. Shah P, Ohlsson A. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. CMAJ 2009;180(12):E99-E108.
96. Simopoulos P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine 2008;233(6):674-88.
97. Spitzer R, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978;35:773-82.
98. Steiner M. Postpartum psychiatric disorders. Canadian Journal of Psychiatry 1990;35(1):89-95.
99. Udechuku A, Nguyen T, Hill R, Szego K. Antidepressants in pregnancy: a systematic review. Australian and New Zealand Journal of Psychiatry 2010;44(11):978-96.
100. WHO & DIMDI (German Institute of Medical Documentation and Information). International Statistical Classification of Diseases and Related Health Problems 10th Revision Version for 2007. http://apps.who.int/classifications/apps/icd/icd10online/ (accessed 2009).
101. Wisner K, Perel J, Peindl K, Hanusa B, Piontek C, Findling R. Prevention of postpartum depression: a pilot randomized clinical trial. American Journal of Psychiatry 2004;161(7):1260-92.
102. Wojcicki JM, Hayman MB. Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression. Journal of Maternal-Fetal and Neonatal Medicine 2011;24(5):680-6.
103. Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research 1999;56(6):565-70.